Suppr超能文献

将靶点固定在玻璃微纤维膜上作为一种无标记的命中化合物鉴定策略。

Target immobilization on glass microfiber membranes as a label-free strategy for hit identification.

作者信息

Wang Yinan, He Yan, Ye Xiaojiao, Zhang Yixiao, Huang Xiuxiu, Liu Hongli, Dong Wenqing, Yang Dongzhi, Guo Dong

机构信息

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, Jiangsu, China.

出版信息

Anal Bioanal Chem. 2023 Nov;415(27):6743-6755. doi: 10.1007/s00216-023-04951-w. Epub 2023 Sep 21.

Abstract

The discovery of novel chemical entities targeting G protein-coupled receptors (GPCRs) is usually guided by their receptor affinity. However, traditional affinity assay methods and hit identification procedures are usually laborious and expensive. In this work, the type-2 vasopressin receptor (VR) was chosen as a prototypical GPCR. Membrane fragments from cells highly expressing SNAP-VR were immobilized on the surface of a glass microfiber (GMF) coated with O-benzylguanine (BG). This was achieved by transferring the benzyl group of BG to the active site of the SNAP-tag through a nucleophilic substitution reaction. As a result, a biofilm called SNAP-VR@GMF-BG was produced that showed good specificity and stability. The adsorption ratio for each VR ligand treated with SNAP-VR@GMF-BG was determined by HPLC and exhibited a good linear correlation with the K value determined by displacement assays. Furthermore, a K prediction assay was performed by comparing the data with that generated by a homogeneous time-resolved fluorescence (HTRF) assay. SNAP-VR@GMF-BG was also used to screen hit compounds from natural products. After SNAP-VR@GMF-BG was incubated with the total extract, the ligand that binds to VR could be separated and subjected to LC‒MS analysis for identification. Baicalein was screened from Clerodendranthus spicatus and verified as a potential VR antagonist. This VR-immobilized GMF platform can help determine the affinity of VR-binding hit compounds and screen the compounds efficiently and accurately.

摘要

靶向G蛋白偶联受体(GPCRs)的新型化学实体的发现通常以其受体亲和力为指导。然而,传统的亲和力测定方法和命中化合物鉴定程序通常既费力又昂贵。在这项工作中,选择2型血管加压素受体(VR)作为典型的GPCR。将高表达SNAP-VR的细胞的膜片段固定在涂有O-苄基鸟嘌呤(BG)的玻璃微纤维(GMF)表面。这是通过亲核取代反应将BG的苄基转移到SNAP标签的活性位点来实现的。结果,产生了一种称为SNAP-VR@GMF-BG的生物膜,其显示出良好的特异性和稳定性。用SNAP-VR@GMF-BG处理的每种VR配体的吸附率通过HPLC测定,并与通过置换试验测定的K值呈现良好的线性相关性。此外,通过将数据与均相时间分辨荧光(HTRF)测定产生的数据进行比较,进行了K预测试验。SNAP-VR@GMF-BG还用于从天然产物中筛选命中化合物。将SNAP-VR@GMF-BG与总提取物孵育后,可以分离与VR结合的配体并进行LC-MS分析以进行鉴定。从肾茶中筛选出黄芩素,并验证其为潜在的VR拮抗剂。这种固定有VR的GMF平台有助于确定与VR结合的命中化合物的亲和力,并高效、准确地筛选化合物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验